# Prospective Study to Measure Vascular Parameters (Ancillary Study of ADEQUATE)

> **NCT02154854** · PHASE4 · UNKNOWN · sponsor: **University Hospital, Tours** · enrollment: 104 (estimated)

## Conditions studied

- De Novo Transplant Disease

## Interventions

- **DRUG:** Tacrolimus targeted half-dose
- **DRUG:** Tacrolimus targeted plain dose

## Key facts

- **NCT ID:** NCT02154854
- **Lead sponsor:** University Hospital, Tours
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-07
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 104 (ESTIMATED)
- **Last updated:** 2014-06-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02154854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02154854, "Prospective Study to Measure Vascular Parameters (Ancillary Study of ADEQUATE)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02154854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*